Will personalized medicine help in 'transforming' the business of healthcare?

Personalized Medicine
David S Lester

Abstract

Personalized medicine is recognized as being a significant part of the solution for providing better healthcare outcomes. However, there are multiple challenges to its adoption from many healthcare stakeholders. The challenges are not technological, but rather involve the development of the appropriate business model, such that all stakeholders can have the necessary incentives to justify adoption. From a commercial perspective, two different industries with distinct business models are involved: pharma and the diagnostics industry. In order for personalized medicine to have its desired impact, it is necessary that innovative business models from various sectors within healthcare are developed. The problem is that different stakeholders have different motivations, but it is all ultimately driven by economic decisions, and empowering of the patient/consumer will also be a significant factor.

References

Mar 21, 2009·Nature Reviews. Drug Discovery·Jerel C DavisPhilip Ma

❮ Previous
Next ❯

Citations

Nov 9, 2014·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·F AntoñanzasR Rodríguez-Ibeas
Jan 8, 2015·Journal of Personalized Medicine·Joshua P Cohen, Abigail E Felix
Nov 1, 2010·Personalized Medicine·Hsin-Lu ChangChin-Chung Shu

❮ Previous
Next ❯

Software Mentioned

Google Health
Microsoft Vault
RoboCop
Theranos
Medco
LabCorp
iTunes

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the International Association of Physicians in AIDS Care : JIAPAC
Philip J Brown
Journal of Pharmacy & Bioallied Sciences
Aarti SharmaDushyant Kumar
Annual Review of Public Health
K E Warner, H A Murt
© 2022 Meta ULC. All rights reserved